Noretreat, I'll be out of the country during the conference but have asked an associate of mine to be there. I'll have him look you up if he confirms his availability.
Not many sellers today, big inefficient spreads on the bid/ask. To those stressed out of recent price action, I think you should go back and read TOB's post that says (paraphrasing) 'at the end of the day the only two prices that matter are what you paid and what you sold for... nothing in between is important.'
For some color, during a conversation this past weekend, I was talking to a very knowledgeable fund manager and we talked about technical trading and chartists, and he asked me,(bio) "how many wealthy technical traders/chartists to you know?" to which I laughed and said "none" and he laughed and said "me neither".
Technical trading/charting is a black art and most retailers don't have the tools / buying power to make it work over the long term. I remember the day trading fab that happened between 95-00 then again in 05-08 with many retailers claiming big gains. But when the academic studies came in, they showed 80% of those traders lost 90% of their money and only 1 in 100 were deemed to have "beat the market".
Investing takes time and patience and for long streches is unprofitable. For example, I was in a meeting Friday with a VC firm who was asking me to look at a deal and when we talked about exit potential, it was in the 8-10 year timeline.
We need to look at CTIX in the same light. Most VC deals utterly fail, as in 60% of deals go BK and return zero. 30% of VC deals will return 1-5x and 10% of deals give you 10-100x (or more). Again that means that only 40% of professional vetted companies, with big backers make it.
I believe CTIX is that low probability 100x investment opportunity. They check all the boxes: disruptive technology, experienced management, executing on the plan and have financing available for the foreseeable future. All elements are needed for potential success.
Biotech's takes HUGE resources (money and time) and CTIX is no exception. We're probably into the fourth or fifth inning with expectations for a return. If we're talking about total EV potential, we're still in the first inning (if Leo decides to build a big pharma).
News 
Market Data 
Discover 
